Droz JP - Search Results

1

Prediction of long-term response after high-dose chemotherapy with autologous bone marrow transplantation in the salvage treatment of non-seminomatous germ cell tumours.

Droz JP, Kramar A, Pico JL. Droz JP, et al. Eur J Cancer. 1993;29A(6):818-21. doi: 10.1016/s0959-8049(05)80416-2. Eur J Cancer. 1993. PMID: 8387318

2

A phase II trial of early intensive chemotherapy with autologous bone marrow transplantation in the treatment of poor prognosis non seminomatous germ cell tumors.

Droz JP, Pico JL, Ghosn M, Kramar A, Rey A, Ostronoff M, Baume D. Droz JP, et al. Bull Cancer. 1992;79(5):497-507. Bull Cancer. 1992. PMID: 1421710 Clinical Trial.

3

Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancer.

Droz JP, Pico JL, Ghosn M, Gouyette A, Baume D, Piot G, Ostronoff M, Theodore C, Beaujean F, Hayat M. Droz JP, et al. Eur J Cancer. 1991;27(7):831-5. doi: 10.1016/0277-5379(91)90127-y. Eur J Cancer. 1991. PMID: 1718349 Clinical Trial.

4

[Salvage chemotherapy of non-seminomatous germ cell tumors. Phase II trial of a combination of etoposide, ifosfamide and high-dose cisplatin].

Ribrag V, Droz JP, Bouleuc C, Theodore C, Ghosn M, Pico JL, Azab M, Ostronoff M, Hayat M. Ribrag V, et al. Among authors: droz jp. Presse Med. 1990 Jul 7-14;19(27):1263-6. Presse Med. 1990. PMID: 2143824 French.

5

[Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)].

Baume D, Pico JL, Droz JP, Ostronoff M, Azab M, Gilles E, Ghosn M, Salloum E, Gouyette A, Beaujean F, et al. Baume D, et al. Among authors: droz jp. Bull Cancer. 1990;77(2):169-80. Bull Cancer. 1990. PMID: 2156588 French.

6

Salvage therapy with methyl-gag, high-dose Ara-C, M-Amsa, and ifosfamide (MAMI) for recurrent or refractory lymphoma.

Hayat M, Ostronoff M, Gilles E, Zambon E, Baume D, Moran A, Carde P, Droz JP, Pico JL. Hayat M, et al. Among authors: droz jp. Cancer Invest. 1990;8(1):1-5. doi: 10.3109/07357909009017540. Cancer Invest. 1990. PMID: 2350713

7

[Chemotherapeutic intensification in germ cell tumors].

Droz JP, Pico JL, Ghosn M, Ostronoff M, Azab M, Theodore C, Hayat M. Droz JP, et al. Bull Cancer. 1990;77(4):349-54. Bull Cancer. 1990. PMID: 2354250 French.

8

Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysis.

Droz JP, Kramar A, Ghosn M, Piot G, Rey A, Theodore C, Wibault P, Court BH, Perrin JL, Travagli JP, et al. Droz JP, et al. Cancer. 1988 Aug 1;62(3):564-8. doi: 10.1002/1097-0142(19880801)62:3<564::aid-cncr2820620321>3.0.co;2-a. Cancer. 1988. PMID: 2455591

9

Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors.

Droz JP, Ribrag V, Ghosn M, Guimares J, Theodore C, Azab M, Ostronoff M, Mahjoubi M, Moran A, Pico J, et al. Droz JP, et al. Prog Clin Biol Res. 1989;303:739-47. Prog Clin Biol Res. 1989. PMID: 2550949 No abstract available.

10

Clinical pharmacology of high-dose etoposide associated with cisplatin. Pharmacokinetic and metabolic studies.

Gouyette A, Deniel A, Pico JL, Droz JP, Baume D, Ostronoff M, le Bail N, Hayat M. Gouyette A, et al. Among authors: droz jp. Eur J Cancer Clin Oncol. 1987 Nov;23(11):1627-32. doi: 10.1016/0277-5379(87)90441-x. Eur J Cancer Clin Oncol. 1987. PMID: 2828072 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters